welcome


Welcome to the Harvard Combined Dermatology Residency Training Program.

The program's mission is to train leaders in dermatology, promote innovation, and foster excellence in research, clinical care, and teaching. We serve the local community through compassionate, cutting-edge patient care and the global community through the development of new knowledge. Our culture supports personal growth, career development, collaboration, and life-long learning.

our executive committee executive committee

From upper left: Drs. David Fisher, Raif Geha, Thomas Kupper and Robert Stern

Our training program is among the oldest and most respected in the world. Four principal Harvard teaching hospitals, each a world leader in patient care, education, and research, comprise the core training experience,. The program was originally established at the Massachusetts General Hospital (MGH). During 1960-1987, the program grew to include Beth Israel Deaconess Medical Center (BIDMC); Brigham and Women's Hospital (BWH); Children's Hospital Boston (CHB); Dana Farber Cancer Institute (DFCI); Lahey Clinic (LC); and the Boston VA HealthCare System (VA). Today, all of these institutions provide residents with integral opportunities to work with outstanding educators and clinical leaders in many subspecialty fields. Our diverse patient population provides our trainees with the experience to treat both common and uncommon diseases of the skin.

Our Executive Committee is comprised of Chairs from our four principal affiliated institutions: Dr. David E. Fisher (Chair, MGH Dermatology), Dr. Raif Geha (Chief, CHB Immunology), Dr. Thomas S. Kupper (Chair, BWH/DFCI Dermatology), and Dr. Robert S. Stern (Chair, BIDMC Dermatology).  This Executive Committee governs the program and provides oversight for Harvard-wide activities. Dr. Rachel V. Reynolds is the Program Director of our residency training programs, which include our advanced dermatology program and three medicine-dermatology programs (see Training).

Our program has a strong reputation for clinical care, teaching and research, both nationally and internationally. Medical discoveries by our faculty include the invention of PUVA and narrow-band UVB phototherapy, establishment of the first pigmented lesion clinic, development of the first laser designed solely for medical use leading to non-scarring treatments for skin lesions, invention of the first selective, sight-sparing treatment for age-related macular degeneration, adaptation of pigment cell-targeting lasers to treat glaucoma, and development of technologies for imaging coronary arteries, GI tract, retina, skin and other organs at high resolution. Many graduates of our training program have become Deans, Department Chairs, and leaders in the field.  Together, our affiliated institutions are the best-funded dermatology research departments in the nation (see Research).
The residency program’s close relationship with these facilities puts our trainees on the forefront of basic and translational research discoveries, providing exposure to the latest in scientific innovation.

Clinical and research interests during residency are encouraged through our elective and mentorship programs (see Training, Educational Curriculum). Many residents pursue our special-track program in their third-year of training, allowing them protected time to develop their research interests.

Thank you for your interest in our programs.

Sincerely,

David E. Fisher, MD, PhD
Professor and Chair,
MGH Department of Dermatology
Raif Geha, MD
Professor and Chief,
CHB Division of Immunology 
Thomas S. Kupper, MD
Professor and Chair,
BWH Department of Dermatology
Robert S. Stern, MD
Professor and Chair,
BIDMC Department of Dermatology
design by symposi.com